Indian researchers find CDKN1B changes impair p27 reducing tamoxifen effectiveness
NewsBytes | April 28, 2026 3:39 AM CST
Study finds CDKN1B repair restores tamoxifen
The study, which looked at 186 patients, found that fixing the CDKN1B gene could help tamoxifen work again in those who'd become resistant.
Even better, another group of drugs called CDK4/6 inhibitors (like palbociclib) seems to work even when p27 is missing.
Researchers think checking p27 levels could help doctors personalize treatments for patients with low p27 levels or at high risk of resistance.
READ NEXT
-
Is A Business Credit Card Right For You? 5 Signs
-
Hyderabad: Breeding syndicate suspected as abandoned Siberian Husky dogs rescued
-
Xavi Simons has sent Tottenham the perfect message as his injury recovery continues
-
Shocking Abduction and Assault Case in Meerut Involving a 13-Year-Old Girl
-
Noida Implements Section 163 of Civil Security Code Amidst Rising Tensions
